Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumor lesions

by | Jun 11, 2014 | Healthcare

Royal Philips (NYSE: PHG; AEX: PHI) today announced the launch of EmboGuide, its latest innovation in interventional oncology, to treat difficult-to-reach tumors or tumors in patients who are deemed unsuitable for surgery.

Philips Respironics
Author: Philips Respironics